Last update :
21/10/2020
Summary lists   Summary lists  

This page permits the cross-consultation of the stability information.

Stability in solutions
Factors which affect stability
Incompatibilities
Route of administration
Route of administration
A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y -      Pdf
Compound Container Solvent Concentration Temperature Storage Length of time References
Injection Cefazolin sodium Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,5 mg/ml 25°C Not specified
8 Day
2372
Injection Cefazolin sodium Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,5 mg/ml 37°C Not specified
24 Hour
2372
Injection Cefazolin sodium Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,5 mg/ml 4°C Not specified
14 Day
2372
Injection Cefotaxime sodium Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,86 mg/ml 37°C Not specified
6 Hour
2374
Injection Cefotaxime sodium Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,92 mg/ml 25°C Not specified
24 Hour
2374
Injection Ciprofloxacin lactate Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,025 mg/ml 25°C Not specified
7 Day
4263
Injection Ciprofloxacin lactate Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,025 mg/ml 37°C Not specified
48 Hour
4263
Injection Deferoxamine mesylate Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,35 mg/ml 25°C Not specified
7 Day
2156
Injection Deferoxamine mesylate Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,35 mg/ml 37°C Not specified
48 Hour
2156
Injection Deferoxamine mesylate Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,35 mg/ml 4°C Not specified
15 Day
2156
Injection Dobutamine hydrochloride Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,0025 mg/ml 26°C Not specified
4 Hour
2371
Injection Dobutamine hydrochloride Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,0025 mg/ml 4°C Not specified
24 Hour
2371
Injection Dobutamine hydrochloride Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,005 mg/ml 26°C Not specified
24 Hour
2371
Injection Dobutamine hydrochloride Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,005 mg/ml 37°C Not specified
24 Hour
2371
Injection Dobutamine hydrochloride Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,005 mg/ml 4°C Not specified
24 Hour
2371
Injection Dobutamine hydrochloride Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,0075 mg/ml 26°C Not specified
24 Hour
2371
Injection Dobutamine hydrochloride Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,0075 mg/ml 37°C Not specified
24 Hour
2371
Injection Dobutamine hydrochloride Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,0075 mg/ml 4°C Not specified
24 Hour
2371
Injection Erythromycin lactobionate Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,15 mg/ml 25°C Not specified
72 Hour
2159
Injection Erythromycin lactobionate Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,15 mg/ml 37°C Not specified
4 Hour
2159
Injection Erythromycin lactobionate Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,15 mg/ml 4°C Not specified
48 Hour
2159
Injection Ofloxacin Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,025 mg/ml 25°C Protect from light
7 Day
2155
Injection Ofloxacin Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,025 mg/ml 37°C Protect from light
48 Hour
2155
Injection Ofloxacin Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,025 mg/ml 4°C Protect from light
14 Day
2155

  Mentions Légales